[HTML][HTML] Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
HA Al-Hussaniy, AF Hassan, AI Oraibi… - Journal of Pharmacy …, 2023 - journals.lww.com
Background: Clinical pharmacogenetics is a rapidly growing field that focuses on the study
of genetic variations and their impact on drug metabolism, efficacy, and safety. Angiotensin II …
of genetic variations and their impact on drug metabolism, efficacy, and safety. Angiotensin II …
Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis
Background Many studies have investigated the association between the angiotensin-
converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphic variant and coronary …
converting enzyme (ACE) gene insertion (I)/deletion (D) polymorphic variant and coronary …
[PDF][PDF] Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease
Coronary artery disease (CAD) is a multifactorial disease influenced by genetic and
environmental factors. Major risk factors of CAD are hypertension, hyperlipidemia, smoking …
environmental factors. Major risk factors of CAD are hypertension, hyperlipidemia, smoking …
The effect of angiotensin converting enzyme (ACE) I/D polymorphism on atherosclerotic cardiovascular disease and cardiovascular mortality risk in non-hemodialyzed …
The association between angiotensin-converting enzyme insertion/deletion (ACE I/D)
polymorphisms and plasma ACE levels may allow for the optimization of a preventive …
polymorphisms and plasma ACE levels may allow for the optimization of a preventive …
The angiotensin converting enzyme D allele is an independent risk factor for early onset coronary artery disease
OBJECTIVE: The role of angiotensin converting enzyme (ACE) gene insertion/deletion (I/D)
polymorphism in early onset coronary artery disease age< 55years (ECAD) is controversial …
polymorphism in early onset coronary artery disease age< 55years (ECAD) is controversial …
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of myocardial infarction in an updated meta-analysis based on 34 993 participants
Y Chen, S Dong, M He, T Qi, W Zhu - Gene, 2013 - Elsevier
The association between angiotensin-converting enzyme insertion/deletion (ACE I/D)
polymorphism and risk of myocardial infarction (MI) has been extensively studied. However …
polymorphism and risk of myocardial infarction (MI) has been extensively studied. However …
Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population
S Mehri, B Baudin, S Mahjoub, A Zaroui… - Genetic testing and …, 2010 - liebertpub.com
Introduction: The role of the insertion/deletion (I/D) polymorphism in the angiotensin-
converting enzyme gene (ACE) on acute myocardial infarction (AMI) is controversial …
converting enzyme gene (ACE) on acute myocardial infarction (AMI) is controversial …
Study of angiotensin-converting enzyme insertion/deletion polymorphism, enzyme activity and oxidized low density lipoprotein in Western Iranians with …
N Nouryazdan, G Adibhesami, M Birjandi… - BMC cardiovascular …, 2019 - Springer
Background It has been indicated that Angiotensin-Converting Enzyme Insertion/Deletion
(ACE I/D) polymorphism (rs4646994) could be regarded as a genetic factor that raises the …
(ACE I/D) polymorphism (rs4646994) could be regarded as a genetic factor that raises the …
Potential genetic risk factors in angiotensin‐converting enzyme‐inhibitor‐induced angio‐oedema
M Bas, TK Hoffmann, B Tiemann… - British journal of …, 2010 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Angiotensin‐converting enzyme
inhibitor (ACEi)‐induced angio‐oedema is an underestimated clinical life‐threatening …
inhibitor (ACEi)‐induced angio‐oedema is an underestimated clinical life‐threatening …
Mathematical modelling of the influence of ACE I/D polymorphism on blood pressure and antihypertensive therapy
E Kutumova, A Kovaleva, R Sharipov, G Lifshits… - Heliyon, 2024 - cell.com
The angiotensin-converting enzyme (ACE) gene (ACE) insertion/deletion (I/D)
polymorphism raises the possibility of personalising ACE inhibitor therapy to optimise its …
polymorphism raises the possibility of personalising ACE inhibitor therapy to optimise its …